Back to Search
AYMEN JABER, PHARMD
PHARMD
Pharmacist
NPI: 1255600466Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
056347(NY)
Research & Publications (20)
Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
PMID 19146672·Ann Clin Microbiol Antimicrob·2009
8-other
Determination of ammonium and organic bound nitrogen by inductively coupled plasma emission spectroscopy.
PMID 19362191·Talanta·2009
8-other
A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis.
PMID 18845005·BMC Neurol·2008
3-trial
The influence of timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery.
PMID 17513652·Anesth Analg·2007
4-observational
Effect of the electronic and physicochemical parameters on the carcinogenesis activity of some sulfa drugs using QSAR analysis based on genetic-MLR and genetic-PLS.
PMID 17307223·Chemosphere·2007
8-other
Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
PMID 17289435·Tuberculosis (Edinb)·2007
8-other
Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis.
PMID 17692727·Clin Ther·2007
3-trial
Immunogenicity comparison of interferon beta-1a preparations using the BALB/c mouse model: assessment of a new formulation for use in multiple sclerosis.
PMID 17802901·New Microbiol·2007
4-observational
Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays.
PMID 17118612·J Pharm Biomed Anal·2007
4-observational
Assessment of the safety, tolerability, and PK/PD properties of two new formulations of subcutaneously administered IFN-beta1a: a double-blind, placebo-controlled comparison with the currently available formulation.
PMID 17595888·Int J Clin Pharmacol Ther·2007
4-observational
Ovine intestinal adenocarcinomas: histologic and phenotypic comparison with human colon cancer.
PMID 16639981·Comp Med·2006
4-observational
Transient neutrophilic thrombophagocytosis associated with Citrobacter freundii septicemia.
PMID 17149945·Arch Pathol Lab Med·2006
5-case
Hydrocarbon polymer analysis by external MALDI fourier transform and reflectron time of flight mass spectrometry.
PMID 16246576·J Am Soc Mass Spectrom·2005
8-other
Trapping of wide range mass-to-charge ions and dependence on matrix amount in internal source MALDI-FTMS.
PMID 16182557·J Am Soc Mass Spectrom·2005
8-other
Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
PMID 15496327·J Pharm Biomed Anal·2004
8-other
Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations.
PMID 15294317·Mol Cell Probes·2004
8-other
Amlodipine besylate-excipients interaction in solid dosage form.
PMID 15000463·Pharm Dev Technol·2004
8-other
[Effect of chronic Chlamydia infection with non-specific inflammation on cardiovascular complications in acute myocardial infarct].
PMID 12728577·Vnitr Lek·2003
8-other
A comparison of the biologic activity of two recombinant IFN-beta preparations used in the treatment of relapsing-remitting multiple sclerosis.
PMID 12581490·J Interferon Cytokine Res·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2819 CHURCH AVE
BROOKLYN, NY 11226 - Phone
- (718) 940-3461
Quick Facts
- NPI
- 1255600466
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile